Boehringer Ingelheim, one of the main pharmaceutical companies in the world, which is also global partner of Ashoka in the “Making more health” project to support social entrepreneurs in the health-care sector, has decided to sustain Cure Thalassemia, with a donation.
I heartily thank Boehringer Ingelheim for their trust in the innovative model of Cure Thalassemia, and also in the people involved in the project, starting with the co-founder and scientific director Dr. Pietro Sodani.
We are studying other joint cooperations for the future.
Recent Comments